Media Summary: At the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum in Dallas, Texas, a number of ... At the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum in Dallas, Texas, Fred D. Lublin, MD, and Patricia K. Coyle, MD, establish the foundational understandings and conjectures of multiple sclerosis ...

Pascal Sati Phd Validating The - Detailed Analysis & Overview

At the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum in Dallas, Texas, a number of ... At the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum in Dallas, Texas, Fred D. Lublin, MD, and Patricia K. Coyle, MD, establish the foundational understandings and conjectures of multiple sclerosis ... Experts react to the current state of multiple sclerosis and highlight next steps in research based on unmet needs in the field. Recorded live on December 13th, 2024 In this recorded Neurology Grand Rounds presentation, Vice Chair of Neurology ... This talk was presented at the FLS 2.0 - Coming Soon to a Testing Center Near You session by Maryam Wagner on Saturday, ...

Fred Lublin, MD, discusses the importance of clinical trial data and the what the language in drug labeling defines broad treatment ... This 30-minute presentation provides an overview of the ATLAS study, the investigational drug, eligibility criteria, and what study ... Fred D. Lublin, MD, and Patricia K. Coyle, MD, outline and elucidate the core phenotypes of multiple sclerosis, including the ... The importance of gadolinium as a contrast agent and central vein sign in scanning and diagnosing multiple sclerosis. Merit Cudkowicz, MD, MSc and Sabrina Paganoni, MD, Ferhan Qureshi, BS, Vice President, Octave Bioscience, Menlo Park, CA, discusses the use of the MS Disease Activity (MSDA) ...

Photo Gallery

Pascal Sati, PhD: Validating the Central Vein Sign in Multiple Sclerosis Diagnosis
Pascal Sati, PhD: Challenges in Imaging for Multiple Sclerosis
Validating biomarkers in MS for clinical practice – a large prospective cohort
The central vein sign in multiple sclerosis
The central vein sign: a novel imaging biomarker for MS diagnosis
MS-ReBS: combining visual, radiological, and blood biomarkers for disability prediction in MS
Translating MS imaging biomarkers into clinical practice
Diagnostic potential of paramagnetic rim lesions in MS
Multiple Sclerosis: What We Understand About Etiology
Next Steps in Research in MS
Pathway to Preventing Neurodegenerative Diseases | Neurology Grand Rounds
Next Steps in Research in MS
View Detailed Profile
Pascal Sati, PhD: Validating the Central Vein Sign in Multiple Sclerosis Diagnosis

Pascal Sati, PhD: Validating the Central Vein Sign in Multiple Sclerosis Diagnosis

At the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum in Dallas, Texas, a number of ...

Pascal Sati, PhD: Challenges in Imaging for Multiple Sclerosis

Pascal Sati, PhD: Challenges in Imaging for Multiple Sclerosis

At the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum in Dallas, Texas,

Validating biomarkers in MS for clinical practice – a large prospective cohort

Validating biomarkers in MS for clinical practice – a large prospective cohort

Pascal Sati

The central vein sign in multiple sclerosis

The central vein sign in multiple sclerosis

Pascal Sati

The central vein sign: a novel imaging biomarker for MS diagnosis

The central vein sign: a novel imaging biomarker for MS diagnosis

Pascal Sati

MS-ReBS: combining visual, radiological, and blood biomarkers for disability prediction in MS

MS-ReBS: combining visual, radiological, and blood biomarkers for disability prediction in MS

Pascal Sati

Translating MS imaging biomarkers into clinical practice

Translating MS imaging biomarkers into clinical practice

Pascal Sati

Diagnostic potential of paramagnetic rim lesions in MS

Diagnostic potential of paramagnetic rim lesions in MS

Pascal Sati

Multiple Sclerosis: What We Understand About Etiology

Multiple Sclerosis: What We Understand About Etiology

Fred D. Lublin, MD, and Patricia K. Coyle, MD, establish the foundational understandings and conjectures of multiple sclerosis ...

Next Steps in Research in MS

Next Steps in Research in MS

Experts react to the current state of multiple sclerosis and highlight next steps in research based on unmet needs in the field.

Pathway to Preventing Neurodegenerative Diseases | Neurology Grand Rounds

Pathway to Preventing Neurodegenerative Diseases | Neurology Grand Rounds

Recorded live on December 13th, 2024 In this recorded Neurology Grand Rounds presentation, Vice Chair of Neurology ...

Next Steps in Research in MS

Next Steps in Research in MS

Experts react to the current state of multiple sclerosis and highlight next steps in research based on unmet needs in the field.

Why Do a Validity Examination for FLS, and by the Way, What is That and how is it Done?

Why Do a Validity Examination for FLS, and by the Way, What is That and how is it Done?

This talk was presented at the FLS 2.0 - Coming Soon to a Testing Center Near You session by Maryam Wagner on Saturday, ...

Secondary Progressive Multiple Sclerosis: Managed Care Implications

Secondary Progressive Multiple Sclerosis: Managed Care Implications

Fred Lublin, MD, discusses the importance of clinical trial data and the what the language in drug labeling defines broad treatment ...

The ATLAS Study: A Clinical Trial for Adults with a Confirmed SOD1 Mutation without Symptoms of ALS

The ATLAS Study: A Clinical Trial for Adults with a Confirmed SOD1 Mutation without Symptoms of ALS

This 30-minute presentation provides an overview of the ATLAS study, the investigational drug, eligibility criteria, and what study ...

Identifying Phenotypes of Multiple Sclerosis

Identifying Phenotypes of Multiple Sclerosis

Fred D. Lublin, MD, and Patricia K. Coyle, MD, outline and elucidate the core phenotypes of multiple sclerosis, including the ...

Role of Gadolinium and Central Vein Sign in MS Imaging

Role of Gadolinium and Central Vein Sign in MS Imaging

The importance of gadolinium as a contrast agent and central vein sign in scanning and diagnosing multiple sclerosis.

HEALEY ALS Platform Trial Weekly Q&A Webinar: April 13, 2023 | Massachusetts General Hospital

HEALEY ALS Platform Trial Weekly Q&A Webinar: April 13, 2023 | Massachusetts General Hospital

Merit Cudkowicz, MD, MSc and Sabrina Paganoni, MD,

An independent focal inflammation cohort – performance of the MSDA validation test algorithm

An independent focal inflammation cohort – performance of the MSDA validation test algorithm

Ferhan Qureshi, BS, Vice President, Octave Bioscience, Menlo Park, CA, discusses the use of the MS Disease Activity (MSDA) ...